🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseDoctor said my fatty liver is GONE - I literally cried — what worked for you?

Doctor said my fatty liver is GONE - I literally cried — what worked for you?

dan_philly Thu, May 16, 2024 at 11:02 PM 14 replies 2,155 viewsPage 1 of 3
This thread is more than 25 months old. Information may be outdated. Consider searching for more recent discussions.
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
May 16, 2024 at 11:02 PM#1

Fatty liver on an incidental scan two years ago and nobody followed it up. Now that I am losing weight I would like to know what to re-measure.

With resmetirom now available for MASH, combination approaches are being explored, so the standard of care in this area is moving faster than most threads assume.

The narrow version of the question is whether normalised enzymes tell you anything about fibrosis, and what the right follow-up measurement is.

Practical detail welcome, however dull — the duller the better.

43 13DadBodDave, AmyNC_wife, SkepticalSean and 40 others
Reply Quote Save Share Report
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
May 16, 2024 at 11:13 PM#2
dan_philly said:
Fatty liver on an incidental scan two years ago and nobody followed it up.

Liver imaging follow-up for liver and MASH: FibroScan at baseline showed CAP score 325 dB/m (moderate steatosis) and stiffness 9.8 kPa (possible fibrosis). Diagnosed with NAFLD.

After 11 months: CAP dropped to 228 dB/m (minimal steatosis) and stiffness normalized to 6.1 kPa. Hepatologist says the liver is essentially healing itself as the metabolic stress resolves.

GLP-1 agonists may become first-line NASH therapy. The Phase 3 data on semaglutide for NASH is very promising.

42 12kim_atl_prep, sarah_TO, wendy_avl and 39 others
Reply Quote Save Share Report
LondonLisa
Member
912
3,456
Mar 2024
London, UK
May 16, 2024 at 11:24 PM#3
Dr.SleepRoch said:
Liver imaging follow-up for liver and MASH: FibroScan at baseline showed CAP score 325 dB/m (moderate steatosis) and stiffness 9.8 kPa (possible…

ATTAIN trial (survodutide) context for liver and MASH: survodutide, a GLP-1/glucagon dual agonist, showed -18.7% body weight at 46 weeks in the Phase 3 ATTAIN trial. NASH resolution was achieved in ~60% of patients[1].

This is relevant to liver and MASH because survodutide's glucagon agonism specifically targets hepatic lipid metabolism — making it potentially the best-in-class agent for NASH/MAFLD comorbid with obesity.

References:
[1] Sanyal AJ, et al. N Engl J Med. 2024.
41 11RetaRick_CA, JenPlateau, SallyK_inj and 38 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
emma_london
Member
312
1,456
Oct 2024
London, UK
May 16, 2024 at 11:35 PM#4
dan_philly said:
Fatty liver on an incidental scan two years ago and nobody followed it up.

This matches mine closely enough to be worth saying so out loud. Posting only so the count is not one.

40 10JessicaM_2024, TomFromTexas, mike.trainer_LA and 37 others
Reply Quote Save Share Report
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
May 17, 2024 at 12:30 AM#5

Clinical perspective, offered as context rather than as advice.

Liver ultrasound comparison for liver and MASH: my hepatologist ordered serial ultrasounds to track NAFLD regression.

Baseline: "Moderate hepatic steatosis, liver span 17.2cm, echogenic texture consistent with fat infiltration"
Month 8: "Mild steatosis, liver span 15.8cm, improved echogenicity"
Month 14: "Minimal to no steatosis, normal liver span 14.5cm, normal echotexture"

My liver literally shrank and de-fattened. The ultrasound tech said she's seen this pattern increasingly in GLP-1 patients and it's remarkable how consistently the fatty liver resolves.

39 9RickReta_CO, PharmHunterJen, TomTeleRx and 36 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register